Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.

Research Base: Children's Oncology Group
NCT ID: NCT01790152
NCI Protocol Number: COG-ALTE11C2
Status: Recruiting

For more information see ClinicalTrials.gov

Interventions

Assessment of Therapy Complications; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration

Condition

Cancer Survivor, Hodgkin Lymphoma, Leukemia in Remission, Lymphoid Leukemia in Remission, Osteosarcoma

Trial Type

Other

See a list of participating sites on ClinicalTrials.gov


˄
BACK TO
TOP